VolitionRx Ltd (VNRX) stock
VNRXNYSEIn Vitro & In Vivo Diagnostic SubstancesFiscal year ends December 31
Số liệu tài chính tới Q2 năm tài chính 2026, quý kết thúc ngày Jun 30, 2026Last filing: 10-Q on Nov 12, 2026Score 4/30
$0.20−0.03 (-13.13%)
Close on Nov 16, 2026Market cap $2.73MP/E –Yield –
VolitionRx operating margin
Operating margin is operating income as a percentage of revenue.
VolitionRx's operating margin for the twelve months ending Jun 30, 2026 was -790.2%. For fiscal 2025 it was -1258.5%, against -2190.9% the year before. The highest annual figure on record is -1258.5% in fiscal 2025.
Annual operating margin
| Period | Period end | Value | Change (pts) |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | -1258.5% | +932.4 |
| FY2024 | Dec 31, 2024 | -2190.9% | +2450.9 |
| FY2023 | Dec 31, 2023 | -4641.8% | +5730.6 |
| FY2022 | Dec 31, 2022 | -10372.4% | +21096.6 |
| FY2021 | Dec 31, 2021 | -31469.0% | +126707.3 |
| FY2020 | Dec 31, 2020 | -158176.2% | −64336.0 |
| FY2019 | Dec 31, 2019 | -93840.2% | −53581.8 |
| FY2014 | Dec 31, 2014 | -40258.4% | −32830.3 |
| FY2012 | Dec 31, 2012 | -7428.0% | – |
Quarterly operating margin
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change (pts) |
|---|---|---|---|
| Q2 FY2026 | Jun 30, 2026 | -1042.5% | +506.1 |
| Q1 FY2026 | Mar 31, 2026 | -543.0% | +1698.1 |
| Q4 FY2025 | Dec 31, 2025 | -1077.9% | +1938.6 |
| Q3 FY2025 | Sep 30, 2025 | -813.2% | +423.6 |
| Q2 FY2025 | Jun 30, 2025 | -1548.6% | +217.6 |
| Q1 FY2025 | Mar 31, 2025 | -2241.1% | +2646.8 |
| Q4 FY2024 | Dec 31, 2024 | -3016.5% | +566.1 |
| Q3 FY2024 | Sep 30, 2024 | -1236.8% | +4000.8 |
| Q2 FY2024 | Jun 30, 2024 | -1766.2% | +2648.4 |
| Q1 FY2024 | Mar 31, 2024 | -4887.9% | +1149.8 |
| Q4 FY2023 | Dec 31, 2023 | -3582.6% | +3108.8 |
| Q3 FY2023 | Sep 30, 2023 | -5237.6% | +19195.3 |
| Q2 FY2023 | Jun 30, 2023 | -4414.5% | +15960.5 |
| Q1 FY2023 | Mar 31, 2023 | -6037.7% | +684.0 |
| Q4 FY2022 | Dec 31, 2022 | -6691.4% | +55001.1 |
| Q3 FY2022 | Sep 30, 2022 | -24432.8% | +5243.0 |
| Q2 FY2022 | Jun 30, 2022 | -20375.0% | +3435.2 |
| Q1 FY2022 | Mar 31, 2022 | -6721.7% | +17113.4 |
| Q4 FY2021 | Dec 31, 2021 | -61692.6% | +17789.4 |
| Q3 FY2021 | Sep 30, 2021 | -29675.8% | +753701.6 |
| Q2 FY2021 | Jun 30, 2021 | -23810.3% | +76543.6 |
| Q1 FY2021 | Mar 31, 2021 | -23835.1% | +1055557.9 |
| Q4 FY2020 | Dec 31, 2020 | -79482.0% | −55054.4 |
| Q3 FY2020 | Sep 30, 2020 | -783377.4% | – |
| Q2 FY2020 | Jun 30, 2020 | -100353.8% | – |
| Q1 FY2020 | Mar 31, 2020 | -1079393.0% | – |
| Q3 FY2019 | Sep 30, 2019 | -24427.6% | – |
See a number that looks wrong?